American Society of Plastic Surgeons logo
Connecticut OFFICE

2 Greenwich Office Park
Suite 210
Greenwich, CT 06831
203 863-0003

Greenwich Hospital Office

77 Lafayette Place
Suite 302
Greenwich, CT 06830
203 863-0003

Dutchess County Office

21 Reade Place

Suite 2100
Poughkeepsie, NY 12601
203 863-0003

Bronx Office

2425 Eastchester Road
Bronx, NY 10469

News

Study Once More Underpins The Clinical Value Of FDA-Cleared Breast Cancer Recurrence Assay

Posted Date: December 22, 2010

Agendia, a world leader in molecular cancer diagnostics, announced recently that together with several groups of scientific collaborators it has identified a major role for TSPYL5 in the genesis of breast cancer.

Agendia, a world leader in molecular cancer diagnostics, announced recently that together with several groups of scientific collaborators it has identified a major role for TSPYL5, one of its MammaPrint breast cancer prognosis genes, in the genesis of breast cancer. The study entitled: “TSPYL5 suppresses p53 levels and function by physical interaction with USP7”, was published in Nature Cell Biology, one of the foremost scientific journals.

Click here to learn more.

PLEASE ENTER YOUR PORTAL LOGIN


CANCEL